Amgen

Amgen teams with Entera to develop oral biologics
Amgen teams with Entera to develop oral biologics
Fierce Biotech
Amgen
Entera Bio
biologics
drug development
Flag link:
Amgen Contributes to Nonprofit to Support Greater Diversity in Clinical Trials
Amgen Contributes to Nonprofit to Support Greater Diversity in Clinical Trials
BioSpace
Amgen
clinical trials
diversity
minorities
oncology
Flag link:
Rheostat Therapeutics Raises $23 Million from Heavyweight Pharma Companies in Series A Round
Rheostat Therapeutics Raises $23 Million from Heavyweight Pharma Companies in Series A Round
CP Wire
Rheostat Therapeutics
Merck
AbbVie
Amgen
Flag link:
Pfizer launches biosimilar version of Amgen's Epogen
Pfizer launches biosimilar version of Amgen's Epogen
Biopharma Dive
Pfizer
biosimilars
Amgen
Epogen
JNJ
Procrit
anemia
Flag link:
Merck, Amgen back a $30M play for Ribometrix — one of the upstarts making its mark in drugging RNA
Merck, Amgen back a $30M play for Ribometrix — one of the upstarts making its mark in drugging RNA
Endpoints
Merck
Amgen
Ribometrix
RNA
Flag link:
Coherus prices biosimilar to Amgen's Neulasta at 33 percent discount
Coherus prices biosimilar to Amgen's Neulasta at 33 percent discount
Reuters
Coherus Biosciences
Amgen
biosimilars
Neulasta
Flag link:
3 Cancer Stocks to Watch in December
3 Cancer Stocks to Watch in December
Motley Fool
Acceleron
luspatercept
Bluebird Bio
bb21217
Amgen
AMG 420
Flag link:
Coherus looks to disrupt Amgen’s $4B Neulasta franchise as analysts look for a deep discount on its copycat price
Coherus looks to disrupt Amgen’s $4B Neulasta franchise as analysts look for a deep discount on its copycat price
Endpoints
Coherus
Neulasta
Mylan
biosimilars
Amgen
Flag link:
Amgen reckons with biosimilar and pricing pressures
Amgen reckons with biosimilar and pricing pressures
Biopharma Dive
Amgen
earnings
biosimilars
Aimovig
Flag link:
Aging Blockbusters Send Amgen Inc.'s Bottom Line Lower
Aging Blockbusters Send Amgen Inc.'s Bottom Line Lower
Motley Fool
Amgen
earnings
Flag link:
This Big Pharma Bet Isn't Paying Off Yet
This Big Pharma Bet Isn't Paying Off Yet
Motley Fool
Big Pharma
biosimilars
Novartis
Amgen
Merck
Pfizer
Biogen
Flag link:
In Unprecedented Move, Amgen Cuts Price Of Cholesterol Drug Repatha By 60%
In Unprecedented Move, Amgen Cuts Price Of Cholesterol Drug Repatha By 60%
Forbes
Amgen
Repatha
drug pricing
Flag link:
Being there: Amgen and Novartis roll out first ad campaign for migraine drug Aimovig
Being there: Amgen and Novartis roll out first ad campaign for migraine drug Aimovig
Fierce Pharma
Novartis
Amgen
Aimovig
DTC ads
television ads
Flag link:
Battle Over Humira Begins in Europe as 5-Year Wait Begins in US
Battle Over Humira Begins in Europe as 5-Year Wait Begins in US
RAPS.org
Europe
AbbVie
Humira
Amgen
Samsung Bioepis
Mylan Labs
Novartis
Sandoz
Fresenius Kabi
Boehringer Ingelheim
Flag link:
Amgen invests £50m in UK genetics firm Oxford Nanopore
Amgen invests £50m in UK genetics firm Oxford Nanopore
Pharmaforum
Amgen
gene sequencing
Oxford Nanopore
Flag link:
Teva slumps after Express Scripts funds migraine rivals in US
Teva slumps after Express Scripts funds migraine rivals in US
Pharmaforum
PBMs
Teva Pharmaceutical
migraines
Ajovy
Express Scripts
Eli Lilly
Amgen
Flag link:
Express Scripts covers Amgen, Lilly migraine therapies, excludes Teva drug
Express Scripts covers Amgen, Lilly migraine therapies, excludes Teva drug
Yahoo/Reuters
Express Scripts
PBMs
migraines
Eli Lilly
Amgen
Teva Pharmaceutical
Emgality
Aimovig
Ajovy
Flag link:
Trump wants drug commercials to include prices. These five companies have the most at stake
Trump wants drug commercials to include prices. These five companies have the most at stake
Stat
Donald Trump
drug ads
drug pricing
Pfizer
AbbVie
Eli Lilly
Amgen
Allergan
Flag link:
Amgen, Novartis and Banner Alzheimer's Institute Team on 2 Alzheimer's Prevention Trials
Amgen, Novartis and Banner Alzheimer's Institute Team on 2 Alzheimer's Prevention Trials
BioSpace
Amgen
Novartis
Alzheimer's disease
preventative medicine
Flag link:
7 drugmakers to watch during Q3 earnings
7 drugmakers to watch during Q3 earnings
Biopharma Dive
earnings
Novartis
Gilead Sciences
Amgen
Pfizer
GSK
AbbVie
Regeneron
Flag link:

Pages